BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38418044)

  • 1. Evaluating the Effectiveness of Take it Personal!+ in People With Mild Intellectual Disability or Borderline Intellectual Functioning and Substance Use Disorder: A Multiple Baseline Single-Case Experimental Study.
    Gosens LCF; Poelen EAP; Didden R; de Jonge JM; Schellekens AFA; VanDerNagel JEL; Onghena P; Otten R
    Behav Ther; 2024 Mar; 55(2):331-346. PubMed ID: 38418044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating a personalized treatment for substance use disorder in people with mild intellectual disability or borderline intellectual functioning: A study protocol of a multiple baseline across individuals design.
    Gosens LCF; Otten R; Didden R; Poelen EAP
    Contemp Clin Trials Commun; 2020 Sep; 19():100616. PubMed ID: 32743120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment for substance-abusing people with intellectual disabilities: intervening on autonomous motivation for treatment entry.
    Frielink N; Schuengel C; Kroon A; Embregts PJ
    J Intellect Disabil Res; 2015 Dec; 59(12):1168-82. PubMed ID: 26369922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of an indicated prevention programme for substance use in individuals with mild intellectual disabilities and borderline intellectual functioning: results of a quasi-experimental study.
    Schijven EP; Hulsmans DHG; VanDerNagel JEL; Lammers J; Otten R; Poelen EAP
    Addiction; 2021 Feb; 116(2):373-381. PubMed ID: 32678489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating a selective prevention program for substance use and comorbid behavioral problems in adolescents with mild to borderline intellectual disabilities: Study protocol of a randomized controlled trial.
    Schijven EP; Engels RC; Kleinjan M; Poelen EA
    BMC Psychiatry; 2015 Jul; 15():167. PubMed ID: 26198744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Take it personal! Development and modelling study of an indicated prevention programme for substance use in adolescents and young adults with mild intellectual disabilities and borderline intellectual functioning.
    Schijven EP; VanDerNagel JEL; Otten R; Lammers J; Poelen EAP
    J Appl Res Intellect Disabil; 2021 Jan; 34(1):307-315. PubMed ID: 32990417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMDR therapy for PTSD symptoms in patients with mild intellectual disability or borderline intellectual functioning and comorbid psychotic disorder: A case series.
    Penninx Quevedo R; de Jongh A; Bouwmeester S; Didden R
    Res Dev Disabil; 2021 Oct; 117():104044. PubMed ID: 34438220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-traumatic stress disorder and substance use disorder in individuals with mild intellectual disability or borderline intellectual functioning: A review of treatment studies.
    Luteijn I; VanDerNagel JEL; van Duijvenbode N; de Haan HA; Poelen EAP; Didden R
    Res Dev Disabil; 2020 Oct; 105():103753. PubMed ID: 32763655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive behaviour therapy (CBT) for anxiety and depression in adults with mild intellectual disabilities (ID): a pilot randomised controlled trial.
    Hassiotis A; Serfaty M; Azam K; Strydom A; Martin S; Parkes C; Blizard R; King M
    Trials; 2011 Apr; 12():95. PubMed ID: 21492437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of psychosocial interventions for children with a psychiatric disorder and mild intellectual disability to borderline intellectual functioning: A systematic literature review and meta-analysis.
    Kok L; van der Waa A; Klip H; Staal W
    Clin Child Psychol Psychiatry; 2016 Jan; 21(1):156-71. PubMed ID: 25633367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.
    Barrowclough C; Haddock G; Wykes T; Beardmore R; Conrod P; Craig T; Davies L; Dunn G; Eisner E; Lewis S; Moring J; Steel C; Tarrier N
    BMJ; 2010 Nov; 341():c6325. PubMed ID: 21106618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the serious game 'You & I' in changing mentalizing abilities of adults with mild to borderline intellectual disabilities: a parallel superiority randomized controlled trial.
    Derks S; van Wijngaarden S; Wouda M; Schuengel C; Sterkenburg PS
    Trials; 2019 Aug; 20(1):500. PubMed ID: 31412913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use among individuals with mild intellectual disability or borderline intellectual functioning in residential care: Examining the relationship between drinking motives and substance use.
    Schijven EP; Didden R; Otten R; Poelen EAP
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):871-878. PubMed ID: 30844128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of emotional and behavioral problems in a personality-targeted prevention program for substance use in adolescents and young adults with intellectual disability.
    Hulsmans DHG; Otten R; Schijven EP; Poelen EAP
    Res Dev Disabil; 2021 Feb; 109():103832. PubMed ID: 33360962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating care for persons with mild intellectual disability or borderline intellectual functioning: a Delphi study on the opinions of primary and professional caregivers and scientists.
    Nouwens PJG; Smulders NBM; Embregts PJCM; van Nieuwenhuizen C
    BMC Psychiatry; 2020 Feb; 20(1):57. PubMed ID: 32039715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive clinical trauma treatment for children and adolescents with mild intellectual disability or borderline intellectual functioning: A pilot study.
    Ooms-Evers M; van der Graaf-Loman S; van Duijvenbode N; Mevissen L; Didden R
    Res Dev Disabil; 2021 Oct; 117():104030. PubMed ID: 34314951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilities.
    Willner P; Rose J; Jahoda A; Stenfert Kroese B; Felce D; MacMahon P; Stimpson A; Rose N; Gillespie D; Shead J; Lammie C; Woodgate C; Townson JK; Nuttall J; Cohen D; Hood K
    Health Technol Assess; 2013 May; 17(21):1-173, v-vi. PubMed ID: 23701738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Symptom Inventory symptom profiles of outpatients with borderline intellectual functioning and major depressive disorder or posttraumatic stress disorder: Comparison with patients from regular mental health care and patients with Mild Intellectual Disabilities.
    Wieland J; Zitman FG
    Res Dev Disabil; 2016; 51-52():153-9. PubMed ID: 26827151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.